Iron deficiency may be linked to non-dialysis-dependent chronic kidney disease and mortality in patients without anemia, according to results of a nationwide cohort study.While iron is a key component ...

在此背景下，具有类过氧化氢酶活性的纳米酶因其独特的优势而备受关注。它们能够在肿瘤微环境中催化过氧化氢分解，原位持续生成氧气，从而改善肿瘤乏氧状态。相比传统方法，纳米酶有效避免了氧气消耗迅速、难以控制或毒性显著等问题，更符合临床实际需求。然而，要实现纳米酶的高效应用，关键在于精准靶向乏氧病灶。然而，目前对乏氧肿瘤细胞表面标志物的了解尚有限，这在一定程度上阻碍了靶向策略的开发。

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

In a groundbreaking study led by Dr. Ying Chen and her team from Ruijin Hospital, Shanghai Jiao Tong University School of ...

PST-611 is a first-in-class non-viral vectorized therapy for the treatment of dry AMD/GA, expressing human transferrin, a highly potent iron regulator, to restore normal iron homeostasis.

Canola and a team of researchers analyzed ferritin, which stores iron and increases during acute inflammation, and ...